Prognosis of relapsed chronic lymphocytic leukemia (CLL) after combined fludarabine, cyclophosphamide and rituximab (FCR) treatment.

Warning

This publication doesn't include Faculty of Medicine. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors	PANOVSKÁ Anna BRYCHTOVÁ Yvona VAŇKOVÁ Gabriela TICHÝ Boris POSPÍŠILOVÁ Šárka MAYER Jiří DOUBEK Michael
Year of publication	2011
Type	Conference abstract
MU Faculty or unit	Central European Institute of Technology
Citation